SCM
UTHR icon

Sterling Capital Management’s United Therapeutics UTHR Stock Holding History

Sterling Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$675K Sell
1,246
-183
-13% -$103K 0.01% 685
2026
Q1 		$847K Sell
1,429
-1,085
-43% -$540K 0.02% 560
2025
Q4 		$1.22M Sell
2,514
-233
-8% -$109K 0.02% 573
2025
Q3 		$1.15M Sell
2,747
-243
-8% -$81.7K 0.02% 592
2025
Q2 		$859K Sell
2,990
-1,825
-38% -$545K 0.01% 687
2025
Q1 		$1.48M Sell
4,815
-1,150
-19% -$394K 0.02% 461
2024
Q4 		$2.1M Buy
5,965
+723
+14% +$266K 0.03% 392
2024
Q3 		$1.88M Buy
+5,242
New +$1.77M 0.02% 399
2019
Q3 		– Sell
-6,287
Closed -$491K – 927
2019
Q2 		$491K Sell
6,287
-20,880
-77% -$1.95M ﹤0.01% 761
2019
Q1 		$3.19M Buy
+27,167
New +$3.17M 0.03% 315
2017
Q4 		– Sell
-18,534
Closed -$2.17M – 961
2017
Q3 		$2.17M Buy
18,534
+1,060
+6% +$135K 0.02% 392
2017
Q2 		$2.27M Sell
17,474
-3,649
-17% -$455K 0.02% 363
2017
Q1 		$2.86M Buy
21,123
+1,080
+5% +$164K 0.03% 304
2016
Q4 		$2.88M Buy
+20,043
New +$2.56M 0.03% 307
2015
Q4 		– Sell
-3,270
Closed -$429K – 1046
2015
Q3 		$429K Buy
+3,270
New +$524K ﹤0.01% 803
2015
Q2 		– Sell
-15,189
Closed -$2.62M – 943
2015
Q1 		$2.62M Sell
15,189
-11,208
-42% -$1.71M 0.02% 261
2014
Q4 		$3.42M Sell
26,397
-328
-1% -$42.3K 0.03% 246
2014
Q3 		$3.44M Sell
26,725
-31
-0.1% -$3.2K 0.04% 229
2014
Q2 		$2.37M Buy
26,756
+308
+1% +$29.6K 0.02% 294
2014
Q1 		$2.49M Buy
26,448
+9,999
+61% +$1.02M 0.02% 274
2013
Q4 		$1.86M Buy
16,449
+285
+2% +$25.7K 0.02% 260
2013
Q3 		$1.27M Buy
16,164
+11,599
+254% +$848K 0.02% 226
2013
Q2 		$300K Buy
+4,565
New +$294K ﹤0.01% 511

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sterling Capital Management's UTHR Position: Q2 2026 in Review

Sterling Capital Management reduced its United Therapeutics (UTHR) stake by 13% in Q2 2026, selling an estimated $103K and leaving 1,246 shares worth $675K. The position accounts for 0.01% of the portfolio, ranked #685.

Sterling Capital Management first reported a position in UTHR in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.44M in Q3 2014. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Sterling Capital Management held 1,246 shares of United Therapeutics worth $675K as of Q2 2026.
  • Sterling Capital Management sold 183 United Therapeutics shares in Q2 2026, an estimated $103K.
  • United Therapeutics made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #685 holding.
  • Sterling Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 23 quarters since.
  • Sterling Capital Management's United Therapeutics position peaked at $3.44M in Q3 2014.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.